Related Experiment Video
Updated: Jun 26, 2025

08:39
Experimental Protocol for Detecting Mitochondrial Function in Hepatocytes Exposed to Organochlorine Pesticides
Published on: September 16, 2020
8.0K
Machine learning-based algorithm identifies key mitochondria-related genes in non-alcoholic steatohepatitis
Longfei Dai1, Renao Jiang1, Zhicheng Zhan1
1Department of General Surgery, The First Affiliated Hospital of Anhui Medical University, 218 Jixi Road, Hefei, 230022, Anhui Province, China.
Lipids in Health and Disease
|May 9, 2024
Summary
Three key mitochondrial genes, Aldo-keto reductase family 1 member B10 (AKR1B10), thymidylate synthase (TYMS), and triggering receptor expressed in myeloid cell 2 (TREM2), are identified as crucial drivers in non-alcoholic steatohepatitis (NASH) progression.
Area of Science:
- Hepatology
- Mitochondrial Biology
- Genetics
Background:
- Hepatocyte mitochondrial dysfunction is implicated in non-alcoholic steatohepatitis (NASH) pathogenesis.
- This dysfunction contributes to abnormal lipid metabolism, redox imbalance, and cell death.
- Identifying key mitochondrial genes in NASH may reveal novel therapeutic targets.
Purpose of the Study:
- To identify critical mitochondrial hub genes associated with non-alcoholic steatohepatitis (NASH).
- To explore the role of these genes in NASH progression and disease severity.
Main Methods:
- A comprehensive analysis of 134 algorithms was performed to identify mitochondrial hub genes in NASH.
- The Random Forest (RF) algorithm demonstrated the highest efficacy in this identification process.
Main Results:
- The RF algorithm identified three upregulated genes: Aldo-keto reductase family 1 member B10 (AKR1B10), thymidylate synthase (TYMS), and triggering receptor expressed in myeloid cell 2 (TREM2).
- These genes positively correlate with inflammation, lipid synthesis, fibrosis, and NASH activity scores.
- The identified genes accurately stratified NASH patients into distinct clusters based on disease severity.
Conclusions:
- AKR1B10, TYMS, and TREM2 are pivotal mitochondrial genes involved in NASH progression.
- These genes serve as potential biomarkers for disease severity and therapeutic targets.

